When did you get so negative BioChica?? The day you sold too early? Aren't you back in yet...you had a nice drop from $2.95 to buy back in!
SYN is holding over $2 PPS. That's amazing -- considering where we were a couple of months ago. It's way undervalued with it's pipeline being what it is, but moreso because of the Intrexon/RJ Kirk investment. Notice how Third Security has bought in? That's Kirk's investment arm. He's jumping in big and betting the pharm, so to speak! Honestly, it's time to back up the truck and I'm surprised people don't see it. I've bought more since the drop. I'm sitting with a lot of shares and not letting any go until we are upwards of $5. Actually, I am hoping for double digits, but I might have to let some of my early shares go if it goes past %5. I have a lot of long term gains right now. I am not in SYN for short term daytrading gains. I pay way too much in taxes to add to my income like that. Whatever happened to 'equal protections' under the law?? Apparently, dollars over a certain amount are not worth protecting as much as dollars under a certain amount! The whole progressive tax system is unconstitutional! IMHO, of course.
Anyway...back to SYN. It's a gift at these levels. What it will take for a pop would be good news -- Effirma, Trimesta, or reaZin/wellZin partnership or collaboration. In case you missed it(and it seems like some of you have), SYN indicated at the end of last year that they are not planning to market R and W without a partner. It's too expensive and marketing is not their expertise. Kuo was going to try to do it, but TPTB figured that it wouldn't work. I look for them to partner or sell the IP outright, so that they can focus on synthetic biologics. Either way, the stock would pop.
Now, what is most interesting to me is that Intrexon buys in and basically AEN changes it's name to EXACTLY what Intrexon does -- synthetic biologics (SYN). Why would Intrexon want them to do that?? Makes me wonder. My best guess is that Intrexon might be using SYN as it's vehicle to go public. Buy it and use it. The float is just right and they've bought enough shares (and will probably continue to do so -- see that huge order at $2.10 out there today??!) to make it a low cost and quick way of accomplishing that. Option B would be to buy SYN outright and make it a division of Intrexon. Both things make sense to me. But no matter what they do, being connected with and invested in by 'the Google of biotech' as Kirk calls Intrexon is a terrific thing!
GLTA -- I'm still holding ALL my shares and picking up more on dips, as I can.
Market Data 
Markets 
AI
